CAS 921195-93-9

GED-0507-34 Levo

CAS : 921195-93-9

GED-0507-34 Levo,(S)-3-(4-Aminophenyl)-2-methoxypropanoic acid,an orally available PPARγ modulator for amelioration of inflammation-driven intestinal fibrosis.

Formule : C₁₀H₁₃NO₃

Degré de pureté : 98.19%

Couleur et forme : Solid

Masse moléculaire : 195.22

Ref: TM-T202784

(S)-3-(4-Aminophenyl)-2-methoxypropanoicacid

CAS : 921195-93-9

Formule : C₁₀H₁₃NO₃

Degré de pureté : 98%

Masse moléculaire : 195.2151

Ref: IN-DA01KKR3

GED-0507-34 Levo

CAS : 921195-93-9

GED-0507-34 Levo

Degré de pureté : ≥98%

Masse moléculaire : 195.22g/mol

Ref: 54-BUP21005

(S)-3-(4-Aminophenyl)-2-methoxypropanoic acid

CAS : 921195-93-9

Degré de pureté : 98%

Masse moléculaire : 195.2180023

Ref: 10-F695535

(S)-3-(4-Aminophenyl)-2-methoxypropanoic acid

CAS : 921195-93-9

(S)-3-(4-Aminophenyl)-2-methoxypropanoic acid is a stereoisomer of 3-aminobenzoic acid, which is a precursor of salicylic acid. (S)-3-(4-Aminophenyl)-2-methoxypropanoic acid has been shown to activate the peroxisome proliferator activated receptor γ (PPARγ), and this activation leads to β-catenin accumulation and regulation of adipose tissue growth. This compound also has been shown to have therapeutic effects on metabolic disorders such as obesity and diabetes by regulating lipid metabolism. The compound also inhibits inflammatory diseases such as bowel disease and inflammatory bowel disease.

Formule : C₁₀H₁₃NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 195.21 g/mol

Ref: 3D-WLB19593